Literature DB >> 14442225

Corticosteroid purpura.

H SCARBOROUGH, S SHUSTER.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES/toxicology; PURPURA/etiology

Mesh：

Substances：

Year:  1960        PMID： 14442225     DOI： 10.1016/s0140-6736(60)92907-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  TRANSPARENT SKIN AND OSTEOPOROSIS: A STUDY IN PATIENTS WITH RHEUMATOID DISEASE.

Authors:  B MCCONKEY; G M FRASER; A S BLIGH
Journal:  Ann Rheum Dis       Date:  1965-05       Impact factor: 19.103

2.  Corticosteroid bruising.

Authors:  H F WEST
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

3.  Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

Authors:  D D McGavin; J Williamson; J V Forrester; W S Foulds; W W Buchanan; W C Dick; P Lee; R N MacSween; K Whaley
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

4.  Adverse effects of inhaled corticosteroids.

Authors:  D L Maxwell; J Webb
Journal:  BMJ       Date:  1989-03-25

5.  Effects of steroid hormones on human fibroblasts in vitro. I. Glucocorticoid action on cell growth and collagen synthesis.

Authors:  W Harvey; R Grahame; G S Panayi
Journal:  Ann Rheum Dis       Date:  1974-09       Impact factor: 19.103

6.  Skin collagen and thickness in Cushing's syndrome.

Authors:  M M Black; S Shuster; E Bottoms
Journal:  Arch Dermatol Forsch       Date:  1973-05-28

7.  Over the counter sale of topical corticosteroids.

Authors:  S Shuster
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

8.  Capillary resistance and skin-fold thickness in patients with rheumatoid arthritis. Effect of corticosteroid therapy.

Authors:  B M Greenwood
Journal:  Ann Rheum Dis       Date:  1966-05       Impact factor: 19.103

9.  Osteoporosis, skin collagen, and androgen.

Authors:  M M Black; S Shuster; E Bottoms
Journal:  Br Med J       Date:  1970-12-26

10.  Combination of a dual 5-lipoxygenase/cyclooxygenase inhibitor with a glucocorticoid results in synergistic topical antiinflammatory activity without inducing skin atrophy.

Authors:  K M Tramposch
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.